Search results for "Marker"

showing 10 items of 3799 documents

Evaluation of polysialic acid in the diagnosis of Wilms' tumor. A comparative study on urinary tract tumors and non-neuroendocrine tumors.

1988

The polysialic acid moiety of the neural cell adhesion molecule has been shown to represent an onco-developmental antigen which can be detected in both embryonic human kidney and Wilms’ tumor but not in normal adult human kidney. In the present comparative study, Wilms’ tumors, clear cell (bone-metastasizing) sarcomas of kidney, cystic nephromas, renal cell carcinomas, transitional cell carcinomas and papillomas of the renal pelvis, ureter and urinary bladder (as well normal transitional epithelium from these regions), Ewing sarcomas, hepatoblastomas, rhabdomyosarcomas, and carcinomas of the stomach, colon, exocrine pancreas, lung, and esophagus, were investigated immunohistochemically for …

Pathologymedicine.medical_specialtyKidneyUrologic NeoplasmsPolysialic acidImmunoblottingAntibodies MonoclonalWilms' tumorGeneral MedicineBiologyNeuroendocrine tumorsTransitional epitheliummedicine.diseaseImmunohistochemistryWilms TumorKidney NeoplasmsMicemedicine.anatomical_structuremedicineBiomarkers TumorSialic AcidsAnimalsNeural cell adhesion moleculeRenal pelvisClear cellVirchows Archiv. B, Cell pathology including molecular pathology
researchProduct

Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with…

1995

Mutations of the p53 gene often result in the overexpression of p53 protein. Previous studies have suggested that the function of p53 and its mutant protein forms may be linked with the disease course of patients with a breast carcinoma. In the present study, we tested 462 primary breast carcinomas for the presence of p53 antigen using immunohistochemical methods employing antibodies against the clone, DO-1. These tumors were also immunohistochemically stained using the monoclonal antibody, MIB-1, in order to demonstrate the presence of Ki67. Comparison of the presence of p53 with other prognostic parameters revealed highly significant negative correlations with estrogen- and progesterone-r…

Pathologymedicine.medical_specialtyMammary glandBreast NeoplasmsDisease-Free SurvivalAntigenmedicineCarcinomaBiomarkers TumorHumansProliferation MarkerCell NucleusEpitheliomabiologybusiness.industryObstetrics and GynecologyAntibodies Monoclonalmedicine.diseasePrognosisImmunohistochemistrySurvival Analysismedicine.anatomical_structureOncologyMutationCancer researchbiology.proteinImmunohistochemistryRegression AnalysisFemaleAntibodyTumor Suppressor Protein p53Breast carcinomabusinessCell DivisionGynecologic oncology
researchProduct

Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune ki…

2009

Objective.To investigate the pathophysiological effect of interleukin 6 (IL-6) on lupus nephritis in MRL-Faslprmice.Methods.We generated IL-6-deficient MRL-Faslprmice using a backcross/intercross breeding scheme. Renal pathology was evaluated using immunohistochemistry detection for macrophages, lymphocytes, vascular cell adhesion molecule-1 (VCAM-1), and TUNEL (terminal deoxynucleotide transferase-mediated dUTP nick end-labeling) for apoptotic cells, and renal IgG and C3 deposition by immunofluorescence staining. Expression of inflammatory markers in the spleen was analyzed by quantitative real-time reverse transcription-polymerase chain reaction. Serum cytokine concentrations were detecte…

Pathologymedicine.medical_specialtyMice Inbred MRL lprImmunologyLupus nephritisVascular Cell Adhesion Molecule-1SpleenKidneyInterferon-gammaMiceLife ExpectancyRheumatologyImmunology and AllergyMedicineAnimalsHumansLupus Erythematosus Systemicfas ReceptorInterleukin 6InflammationMice KnockoutKidneyMice Inbred BALB CLupus erythematosusbiologybusiness.industryInterleukin-6Kidney metabolismmedicine.diseaseLupus NephritisInterleukin-10Proteinuriamedicine.anatomical_structureRenal pathologyImmunologybiology.proteinFemalebusinessBiomarkersSpleenKidney diseaseSignal TransductionThe Journal of rheumatology
researchProduct

Blastic Plasmacytoid Dendritic Cell Neoplasm

2020

Clinical and biological presentation of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) is depicted to highlight criteria that might alert physicians. Diagnosis of BPDCN is still challenging and requires (1) immunophenotyping of blood or bone marrow aspiration using several markers (CD4, CD56, HLA-DR, myeloid and lymphoid lineage markers) and should include pDC markers such as CD123, cTCL1, CD303, and CD304, and/or (2) pathologic analysis of cutaneous lesions, also with immunohistochemistry using markers specific to BPDCN.

Pathologymedicine.medical_specialtyMyeloidbusiness.industryLineage markersHematologyBlastic plasmacytoid dendritic cell neoplasm3. Good health03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureImmunophenotypingOncology030220 oncology & carcinogenesisMedicineImmunohistochemistryInterleukin-3 receptorBone marrowPresentation (obstetrics)business030215 immunologyHematology/Oncology Clinics of North America
researchProduct

Molecular markers of cell adhesion in ameloblastomas. An update

2013

Ameloblastoma is the most common odontogenic tumor of epithelial origin, and though it is of a benign nature, it frequently infiltrates the bone, has a high rate of recurrence and could potentially become malignant. Cellular adhesion potentially plays an important role in the manifestation of these characteristics and in the tumor biology of ameloblastomas. Losses of cell-cell and extracellular matrix adhesion and cohesion are among the first events that occur in the invasion and growth of tumors of epithelial origin. The present review includes a description of the molecules that are involved in cell adhesion as reported for various types of ameloblastomas and discusses the possible roles …

Pathologymedicine.medical_specialtyOdontogenic TumorsOdontologíaReviewBiologyAmeloblastomaExtracellular matrixmedicineHumansAmeloblastomaCell adhesionGeneral DentistryOral Medicine and PathologyTumor biologyOdontogenic tumorAdhesionmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryCell Adhesion MoleculesBiomarkers
researchProduct

Pulmonary haemangiolymphangioma – a new entity of pulmonary vascular tumours?

2008

Pathologymedicine.medical_specialtyPediatricsLung NeoplasmsHistologyMEDLINEAntigens CD34Lung pathologyPathology and Forensic MedicineHemangiomaAntibodies Monoclonal Murine-DerivedText miningAntigenBiomarkers TumormedicineHumansHemangioma CapillaryLungLymphangiomabiologybusiness.industryAntibodies MonoclonalGeneral Medicinemedicine.diseaseHemangioma CavernousFluorescent Antibody Technique DirectMonoclonalbiology.proteinAntibodybusinessHistopathology
researchProduct

Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells

2008

Glaucoma is characterized by a loss of retinal ganglion cells (RGC) which is associated with a decrease of visual function. Neuroprotective agents as a new therapeutic strategy could prevent the remaining neurons from apoptotic cell death. Previous studies have shown the involvement of the Cyclooxygenase (COX)-2 signalling in the apoptotic death of neurons. Herein we investigated the neuroprotective effect of COX-1/COX-2- and selective COX-2- inhibitors on apoptotic. R28, a neuroretinal cell line and determined the PGE2 levels by ELISA. Furthermore we investigated differences in protein expression in the cells after exposure to elevated pressure compared to untreated cells by ProteinChip a…

Pathologymedicine.medical_specialtyPharmacologyProteomicsRetinal ganglionNeuroprotectionUbiquitinmedicineOriginal ResearchPharmacologylcsh:R5-920biomarker neuroprotection of apoptotic neuroretinal cellsbiologyBiochemistry (medical)apoptosiscyclooxygenaseretinal ganglion cellsSeldi/MaldiApoptosisCell cultureCelecoxibbiology.proteinMolecular MedicineneuroprotectionCyclooxygenasePGE2lcsh:Medicine (General)medicine.drugBiomarker Insights
researchProduct

Caki-1 Cells Represent an in vitro Model System for Studying the Human Proximal Tubule Epithelium

2007

<i>Background/Aims:</i> The human proximal tubule (PT) epithelium is distinguished from other nephron segments via several unique characteristics. Studies assessing PT epithelium increasingly employ cell lines, bypassing the complexity of primary cell cultures. However, few human model systems exist for studying PT cells in vitro. The current work involves an intensive characterization of Caki-1 cells, a commercially available human renal cell line. <i>Methods:</i> Caki-1 cells were validated as a representative model system for PT cell research via morphological, physiological and biochemical investigations including light and transmission electron microscopy, trans…

Pathologymedicine.medical_specialtyPhysiologyCellular differentiationNephronBiologyIn vitro modelKidney Tubules ProximalCell Line TumorGeneticsmedicineHumansCells CulturedEpithelial CellsGeneral MedicineKidney NeoplasmsIn vitroEpitheliumCell biologymedicine.anatomical_structureNephrologyCaco-2Cell cultureProximal tubuleCaco-2 CellsBiomarkersNephron Experimental Nephrology
researchProduct

Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture …

2005

To better understand the relationship between tumor heterogeneity, differentiation, and metastasis, suitable experimental models permitting in vitro and in vivo studies are necessary. A new variant cell line (T84SF) exhibiting an altered phenotype was recently selected from a colon cancer cell line (T84) by repetitive plating on TNF-alpha treated human endothelial cells and subsequent selection for adherent cells. The matched pair of cell lines provides a useful system to investigate the extravasation step of the metastatic cascade. Since analysis of morphological differences can be instructive to the understanding of metastatic potential of tumor cells, we compared the ultrastructural and …

Pathologymedicine.medical_specialtyProgrammed cell deathColon carcinoma ; Tumor cells;. Ultrastructure ; Metastasis .;Apoptosis . ;Bcl-XL;Bcl-XLbcl-X ProteinColon carcinomaApoptosis. UltrastructureBiologyAdenocarcinomaMetastasis .Pathology and Forensic MedicineMetastasischemistry.chemical_compoundMicroscopy Electron TransmissionIn vivoCell Line TumorTumor cellmedicineBiomarkers TumorHumansNeoplasm MetastasisMolecular BiologyCell NucleusCytoplasmic VesiclesTyrosine phosphorylationCell BiologyGeneral Medicinemedicine.diseaseApoptosis .In vitroPhenotypechemistryPleomorphism (cytology)ApoptosisCell cultureGelatinasesColonic NeoplasmsCancer researchDisease ProgressionSignal Transduction
researchProduct

Acanthocyturia—A characteristic marker for glomerular bleeding

1991

Acanthocyturia—A characteristic marker for glomerular bleeding. Erythrocyte morphology by phase contrast microscopic examination (PCM) of the urine is widely employed in distinguishing glomerular from nonglomerular bleeding. The proposed percentages of dysmorphic red cells are significant for glomerular bleeding in the range of 10 to 80% in the literature, because there is no clear cut definition of “dysmor-phism.” In the present study midstream urine samples of 351 patients with hematuria (> 8 erythrocytes/μl) and of 33 healthy controls were examined. The various dysmorphic red cells were analyzed by PCM according to a detailed hematological classification. Most of the dysmorphic red cells…

Pathologymedicine.medical_specialtyRenal glomerulusKidney GlomerulusEchinocyteAcanthocytesHemorrhageUrineurologic and male genital diseasesBiopsymedicineHumansUrine cytologyKidneymedicine.diagnostic_testRed Cellurogenital systembusiness.industryOsmolar ConcentrationGlomerulonephritisHydrogen-Ion Concentrationmedicine.diseasefemale genital diseases and pregnancy complicationsProteinuriamedicine.anatomical_structureNephrologyKidney DiseasesAcanthocytebusinessBiomarkersKidney International
researchProduct